🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to evaluate the therapeutic effect of therapy with...
Status
Not Yet Recruiting
Location
Medimprove
Start Date
2025-05
Trial ID
NCT06937216
Treatments Being Tested
This Phase 2, multi-center, open-label extension trial will provide CAP-100...
Status
Completed
Location
University of Florida
Start Date
2018-06-21
Trial ID
NCT06304064
Treatments Being Tested
This is a multi-center, open-label study to evaluate the long-term safety o...
Status
Completed
Location
Hiroskai University Hospital
Start Date
2016-07-29
Trial ID
NCT02870348
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of niraparib in ...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2019-01-25
Trial ID
NCT03748641
DMX-200 (repagermanium) is a C-C chemokine receptor type 2 (CCR2) inhibitor...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-05-30
Trial ID
NCT05183646
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate t...
Status
Recruiting
Location
UZ Leuven
Start Date
2026-08
Trial ID
NCT07587242
The purpose of this study is to evaluate the clinical efficacy and safety o...
Status
Active Not Recruiting
Location
Advanced Clinical Research Center
Start Date
2024-12-04
Trial ID
NCT06741969
Treatments Being Tested
This study is researching an experimental drug called REGN13335. The study ...
Status
Recruiting
Location
University of Colorado Denver
Start Date
2026-05-06
Trial ID
NCT07318597
The goal of this clinical study is to learn about the safety and efficacy o...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2024-10-09
Trial ID
NCT06630286
Treatments Being Tested
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlle...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-09-15
Trial ID
NCT04462770
Treatments Being Tested